Fujian Shengdi Pharmaceutical Co. Ltd, a wholly-owned subsidiary of Jiangsu Hengrui Medicine Co. Ltd in Xiamen, is dedicated to developing and producing innovative drugs and specialty infusions for anti-infection and anesthesia. It aims to become a leading chain for new drug innovation, transformation, evaluation and production. The Xiamen R&D institute applies the existing production line of the Xiamen factory for new drug research and transformation, and is positioned as the research transformation and production base for innovative drugs.

Disease Domain	Count

Nervous System Diseases	3
Neoplasms	2
Infectious Diseases	2
Endocrinology and Metabolic Disease	2

Top 5 Drug Type	Count

Small molecule drug	5
Chemical drugs	3
Synthetic peptide	1
siRNA	1

Top 5 Target	Count

HBV RNA	1
1,3-beta-glucan synthase	1
NK1R(Neurokinin 1 receptor)	1
5-HT3A receptor x NK1R	1
GIPR x GLP-1R	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 25 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

IND Application

IND Approval

Phase 1

Phase 2

Phase 3

NDA/BLA

Other

Current Projects

Drug(Targets)	Indications	Global Highest Phase

HR-20013 ( 5-HT3A receptor x NK1R )	Nausea More	Phase 3
HRS-9531 ( GIPR x GLP-1R )	Polycystic Ovary Syndrome More	Phase 2
HRS-5635 ( HBV RNA )	Hepatitis B, Chronic More	Phase 2
Fosrolapitant ( NK1R )	Vomiting More	Phase 2
HRS-9432 ( 1,3-beta-glucan synthase )	Candidemia More	Phase 2

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis